Novel Combinations of Immunotherapies or DNA Damage Repair Inhibitors in Platinum-Refractory Extensive-Stage Small-Cell Lung Cancer: The Phase II Baltic Study

The Phase II, multiarm, signal-searching BALTIC study assessed novel treatment combinations for platinum-refractory/resistant extensive-stage small-cell lung cancer.